Investor mix
14 investors on record; lead investors include Yangzhou Guojin Investment Group, Forstone Capital, Detong Capital, CICC Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 29% |
| Private equity | 5 | 36% |
| Other / undisclosed | 5 | 36% |
Developer of the NGS-based platform to detect cancer
14 investors on record; lead investors include Yangzhou Guojin Investment Group, Forstone Capital, Detong Capital, CICC Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 29% |
| Private equity | 5 | 36% |
| Other / undisclosed | 5 | 36% |